Viromed Medical AG Partners with AMAMUS Vet for ViroCAP® VET in Veterinary Medicine

Viromed Medical AG has announced an exclusive distribution partnership with Lang Life Sciences GmbH's AMAMUS Vet for its ViroCAP® VET cold plasma medical device. This agreement covers the distribution in Germany, Austria, and Switzerland, targeting veterinary applications for skin conditions in animals. Under this deal, AMAMUS Vet will sell a minimum of 1,000 ViroCAP® units within the first year, starting deliveries by the end of August.

Jan Lang, founder of Lang Life Sciences, emphasizes the reduction of antibiotic use in veterinary medicine. Viromed's entry into this market marks a strategic move, leveraging Lang's expertise to establish ViroCAP® as a viable treatment option. The partnership also holds the potential to enter the U.S. market in the future, tapping into Viromed's pioneering cold plasma technology applications.